Skyrocket U.k. Limited

Skyrocket Phytopharma, based in Croydon, UK, is a small holding company with an active status, established 21 years ago in 2003. It employs just two people and holds £5,433 in assets, operating from a virtual address shared by eleven other companies. The company has two directors and one owner. Skyrocket Phytopharma regularly imports toys, games, and sports equipment, with 14 months of import activity recorded, the last in 2021. It has also engaged in exporting machinery parts, though less frequently, with just one month of export activity as of 2018.

The company’s website focuses on early detection of peripheral neuropathy, a common complication of diabetes. Skyrocket Phytopharma offers Neuropad, a 10-minute screening test, and a foot repair foam, targeting the 4.9 million people in the UK diagnosed with diabetes. The website emphasizes the seriousness of diabetic foot disease, highlighting the risk of ulcers, amputations, and reduced life expectancy. It’s clear that the company is positioning itself as a provider of innovative diagnostic and therapeutic solutions within the digital therapeutics (DTx) space.

Financially, Skyrocket Phytopharma shows a concerning trend. Current assets have plummeted by a staggering 96%, dropping from £140,000 to just £5,400. Bank cash reserves have also experienced a dramatic decrease, falling 88% to £5,100. Debtors have suffered a similar fate, shrinking by 99% to just £290. While creditors have also decreased, by 88% to £1,200, the overall picture suggests a company struggling to maintain its financial footing. Equity has also seen a substantial drop, falling 98% to just £4,200. The company’s small size (meeting two of three criteria for a small company) does allow for agility, but the sharp decline in assets raises questions about its long-term viability. No auditor is mentioned, likely due to its small size, meaning the figures are unaudited.

In short, Skyrocket Phytopharma appears to be burning through money. While its focus on digital therapeutics and early neuropathy detection shows promise, the company's financials suggest a challenging period. It remains to be seen whether the company can stabilize its finances and continue its mission.

Registered in England/Wales under the registration number 04840993, with a registered address at CR0 0XZ, United Kingdom, Croydon, Surrey, Airport House Suite 43 - 45, Purley Way.

WARNING:The numbers have been rounded for simplicity and may be inaccurate.Please, refer to the latest financial report for verification.